Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
The British Journal of Ophthalmology
|
July 8, 2011
Changing trends in keratoplasty in the West of Scotland: a 10-year review
Darren S J Ting, C Y Sau, S Srinivasan, et al.
Journal of Gastrointestinal Oncology
|
September 17, 2021
Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center
Rucha M Shah, Sarah Sheikh, Jimmy Shah, et al.
The British Journal of Ophthalmology
|
March 15, 2006
Subjective and objective performance of the Lenstec KH-3500 "accommodative" intraocular lens
J S Wolffsohn, S A Naroo, N K Motwani, et al.
Journal of Viral Hepatitis
|
September 11, 2015
Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial
M Lagging, A Brown, P S Mantry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 2, 2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials
Edward Tam, Anne F Luetkemeyer, Parvez S Mantry, et al.
Gastroenterology
|
March 16, 2016
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease
Paul J Pockros, K Rajender Reddy, Parvez S Mantry, et al.
Journal of Hepatology
|
October 10, 2020
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Catherine Frenette, Zeid Kayali, Edward Mena, et al.
Kidney International Reports
|
February 19, 2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease
Eric Lawitz, Edward Gane, Eric Cohen, et al.
Hepatology (Baltimore, Md.)
|
September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Hepatology (Baltimore, Md.)
|
November 8, 2024
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial
Benjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
The British Journal of Ophthalmology
|
July 8, 2011
Changing trends in keratoplasty in the West of Scotland: a 10-year review
Darren S J Ting, C Y Sau, S Srinivasan, et al.
Journal of Gastrointestinal Oncology
|
September 17, 2021
Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center
Rucha M Shah, Sarah Sheikh, Jimmy Shah, et al.
The British Journal of Ophthalmology
|
March 15, 2006
Subjective and objective performance of the Lenstec KH-3500 "accommodative" intraocular lens
J S Wolffsohn, S A Naroo, N K Motwani, et al.
Journal of Viral Hepatitis
|
September 11, 2015
Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial
M Lagging, A Brown, P S Mantry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 2, 2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials
Edward Tam, Anne F Luetkemeyer, Parvez S Mantry, et al.
Gastroenterology
|
March 16, 2016
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease
Paul J Pockros, K Rajender Reddy, Parvez S Mantry, et al.
Journal of Hepatology
|
October 10, 2020
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Catherine Frenette, Zeid Kayali, Edward Mena, et al.
Kidney International Reports
|
February 19, 2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease
Eric Lawitz, Edward Gane, Eric Cohen, et al.
Hepatology (Baltimore, Md.)
|
September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Hepatology (Baltimore, Md.)
|
November 8, 2024
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial
Benjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Page
of 4